Riverview Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Riverview Trust Company's VRTX Position: Q3 2026 in Review
Riverview Trust Company opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 55 shares worth $28.8K. The stake represents 0.03% of the portfolio and ranks #130 among its holdings. This is a return to the name: Riverview Trust Company previously reported a position in VRTX as recently as Q1 2026.
Riverview Trust Company first reported a position in VRTX in Q1 2022 and has held it in 17 quarters since. The position peaked at $121K in Q1 2025. 1,792 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Riverview Trust Company held 55 shares of Vertex Pharmaceuticals worth $28.8K as of Q3 2026.
- Vertex Pharmaceuticals was a new Riverview Trust Company position in Q3 2026.
- Vertex Pharmaceuticals made up 0.03% of Riverview Trust Company's portfolio in Q3 2026, its #130 holding.
- Riverview Trust Company first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
- Riverview Trust Company's Vertex Pharmaceuticals position peaked at $121K in Q1 2025.
- 1,792 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Riverview Trust Company's 13F filing for Q3 2026, filed 13 Nov 2026.